| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/06/1996 | CN1117864A "Zaishengwan" - a Chinese proprietary medicine for treatment of hemiplegia |
| 03/06/1996 | CN1117848A Application of "Wujinshi" (a Chinese medicine) effective component in medicines with invigerating blood-circulation and regulating cell function |
| 03/06/1996 | CN1117827A Biochemical health-care drink |
| 03/06/1996 | CN1031173C Process for producing bioactive material, and product therefrom |
| 03/05/1996 | US5496950 Antiinflammatory agents |
| 03/05/1996 | US5496821 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them |
| 03/05/1996 | US5496807 Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it |
| 03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
| 03/05/1996 | US5496637 Hollow fiber membranes immersed in solution of polyacrylic acid |
| 02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
| 02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
| 02/29/1996 | WO1996005860A1 A method of treating a patient with a biologically active compound |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005740A1 Nervonic acid compositions |
| 02/29/1996 | WO1996001324A3 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 02/29/1996 | CA2196311A1 Genetically engineered swine cells |
| 02/28/1996 | EP0698392A1 Compositions containing a RAR alpha specific ligand and at least one fatty acid |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0698087A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697876A1 Xenograft thymus |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/28/1996 | EP0697857A1 Hookworm anticoagulant |
| 02/28/1996 | CN1117393A Snake fat ointment |
| 02/28/1996 | CN1117385A Medicinal granules for treating pediatric anorexia |
| 02/28/1996 | CN1117352A Chinese forest frog extract |
| 02/27/1996 | US5494819 Pure culture of Pantoea agglomerans ferm BP-3511 |
| 02/27/1996 | US5494682 Encapsulated biomass in crosslinked polymer material |
| 02/27/1996 | US5494675 Using alkali and ammonium salt of low molecular weight huminate |
| 02/27/1996 | US5494664 Bifidobacteria |
| 02/27/1996 | CA2046970C Anti-inflammatory composite |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005301A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005290A1 Bone precursor cells: compositions and methods |
| 02/22/1996 | WO1996005289A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 02/22/1996 | WO1996005288A2 T cell activation |
| 02/22/1996 | WO1996005287A1 A method for the isolation of t cells from peripheral blood |
| 02/22/1996 | WO1996005164A1 Anti-inflammatory preparation |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | WO1996004929A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 02/22/1996 | WO1996004789A1 A method of selectively destroying neoplastic cells |
| 02/22/1996 | CA2200197A1 Bone precursor cells: compositions and methods |
| 02/22/1996 | CA2197801A1 T cell activation |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2196756A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 02/22/1996 | CA2196422A1 Anti-inflammatory preparation |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0696933A1 Composition and method for enrichment of white blood cells from whole human blood |
| 02/21/1996 | CN1117079A Siquan (strontium spring) white spirit and its making method |
| 02/21/1996 | CN1117027A Saltish mineral water |
| 02/21/1996 | CN1116949A Chinese herb medicine for external use of gynecopathy |
| 02/21/1996 | CN1116948A Kechuanyu syrup for treating cough and asthma |
| 02/21/1996 | CN1116945A Capsule for gastric diseases |
| 02/21/1996 | CN1116940A Medicinal composite for rheumatism |
| 02/21/1996 | CN1116937A Chinese herb medicine preparation for treating prostate hyperplasia and its preparing method |
| 02/21/1996 | CN1116932A Biological bacteriostat and its preparing method |
| 02/21/1996 | CN1116931A Ganlong extract and Ganlong preparation |
| 02/21/1996 | CN1116930A 1,6-diphosphofructose sodium salt capsule |
| 02/21/1996 | CN1116907A Beautifying oral preparation containing germanium and selenium spirulina and its preparing method |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/15/1996 | WO1996004395A1 Recombinant virus vectors |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004026A1 Injectable non-immunogenic cartilage and bone preparation |
| 02/15/1996 | WO1996004019A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | WO1996003997A2 Treatment of cancer using hsv mutant |
| 02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196776A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | CA2196168A1 Recombinant virus vectors |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/14/1996 | EP0696644A1 Apparatus for inhibiting glycolysis in blood samples |
| 02/14/1996 | EP0696639A1 Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
| 02/14/1996 | EP0696595A1 Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| 02/14/1996 | EP0696594A1 Human interleukin 6 inhibitor |
| 02/14/1996 | EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels |
| 02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
| 02/14/1996 | EP0696312A1 Process for obtaining high-purity egg oil and use thereof |
| 02/14/1996 | EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 02/14/1996 | EP0484517B1 Venting system |
| 02/14/1996 | CN1116533A Venereal disease curing powder medicine and method for preparing same |
| 02/14/1996 | CN1116527A Medicine for treatment of osteoporosis |
| 02/14/1996 | CA2155920A1 Use of interferon for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/11/1996 | CA2155629A1 Human interleukin 6 inhibitor |
| 02/08/1996 | WO1996003520A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003194A1 Fibrous web and process of preparing same |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003149A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 02/08/1996 | WO1996003139A1 Use of nitric oxide or nitric oxide adducts to preserve platelets |
| 02/08/1996 | WO1996003136A1 Inhibition of platelet binding |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |